Glenmark reports 11% rise in Q3 consolidated net profit

15 Feb 2019 Evaluate

Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2018.

The company has reported a rise of 0.90% in its net profit at Rs 195.87 crore for the quarter under review as compared to Rs 194.12 crore for the same quarter in the previous year. Total income of the company increased by 13.17% at Rs 1547.40 crore for Q3FY19 as compared Rs 1367.29 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 11.08% in its net profit at Rs 116.34 crore for the quarter under review as compared to Rs 104.74 crore for the same quarter in the previous year. Total income of the company increased by 12.18% at Rs 2446.03 crore for Q3FY19 as compared Rs 2180.50 crore for the corresponding quarter previous year.

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×